Subcutaneous Morphine Dosing for a 50 kg Child
For a 50 kg child requiring subcutaneous morphine for pain management, administer 100-150 micrograms/kg every 4-6 hours, which translates to 5-7.5 mg per dose for this specific patient 1.
Age-Based Dosing Algorithm
The appropriate dose depends critically on the child's age, not just weight:
- If age 1-5 years: 100-150 micrograms/kg every 4-6 hours = 5-7.5 mg per dose
- If age 5-18 years: 200-300 micrograms/kg as single dose adjusted to response = 10-15 mg per dose 1
For a 50 kg child, they are most likely in the 5-18 year age range, making the higher dose range (10-15 mg) more appropriate.
Practical Dosing Guidance
Start conservatively at the lower end of the range (5-10 mg) and titrate upward based on pain response and tolerance. The 2024 ESPA guidelines provide clear age-stratified dosing that prioritizes safety while ensuring adequate analgesia 1.
Key Considerations:
- Frequency: Administer every 4-6 hours as needed
- Maximum single dose: Generally cap at 10 mg for younger children (1-5 years) per guideline recommendations
- Monitoring: Observe closely for respiratory depression, especially in the first 24-72 hours
- Opioid-naive patients: If the child has not received opioids previously, start at the absolute lowest dose in the range
Important Caveats
Subcutaneous administration requires adequate monitoring - this route is appropriate for ward-based care but demands regular assessment of respiratory status, sedation level, and pain scores 2. The 1993 British Journal of Anaesthesia study demonstrated safety of continuous subcutaneous morphine infusions in children with 97% of oxygen saturation readings >94%, but this required structured nursing protocols 2.
Age trumps weight in pediatric morphine dosing due to developmental pharmacokinetic differences. A 50 kg adolescent metabolizes morphine differently than a 50 kg younger child with obesity, making age-based stratification essential 1.
The evidence strongly supports these weight-based, age-stratified doses from the most recent (2024) European pediatric pain guidelines, which synthesize current best practices for subcutaneous opioid administration in children 1.